BERLIN—Bayer Chief Govt Invoice Anderson mentioned the corporate would bounce again rapidly from a latest spate of unhealthy information, and warned {that a} breakup of the pharmaceutical and agricultural firm was no common remedy for its illnesses.
A stream of adverse information has rekindled calls from traders for Bayer to unlock worth by spinning off its models into separate companies. However in an interview with The Wall Road Journal this week, Anderson mentioned the corporate couldn’t be distracted from the powerful restructuring to repair the companies.
Copyright ©2023 Dow Jones & Firm, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
